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Abstract
MAK-V/Hunk is a scantily characterized AMPK-like protein kinase. Recent findings identified MAK-V as a pro-survival and
anti-apoptotic protein and revealed its role in embryonic development as well as in tumorigenesis and metastasis. However
molecular mechanisms of MAK-V action and regulation of its activity remain largely unknown. We identified Nedd4 as an
interaction partner for MAK-V protein kinase. However, this HECT-type E3 ubiquitin ligase is not involved in the control of
MAK-V degradation by the ubiquitin-proteasome system that regulates MAK-V abundance in cells. However, Nedd4 in an
ubiquitin ligase-independent manner rescued developmental defects in Xenopus embryos induced by MAK-V over-
expression, suggesting physiological relevance of interaction between MAK-V and Nedd4. This identifies Nedd4 as the first
known regulator of MAK-V function.
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Introduction
MAK-V/Hunk belongs to the group of AMPK-like protein
kinases [1,2]. Although the biological function of MAK-V is
poorly understood, this protein was recently implicated in the
development and progression of mammary gland cancer [3,4].
However, in another study MAK-V was identified as a suppressor
of basal type breast cancers metastasis [5], suggesting cell-type
specific mode of MAK-V action. Tumor-promoting properties of
MAK-V were linked to anti-apoptotic activity of MAK-V in Her2-
overexpressing cells [3]. This is in line with the recently described
pro-survival and anti-apoptotic effects of MAK-V in PC12 cells
[6]. However molecular mechanisms underlying these effects of
MAK-V remain unknown. The only definite association of MAK-
V with a particular molecular cascade is the modulating effect of
MAK-V on Wnt signaling presumably via MAK-V-directed
phosphorylation of Dsh, which was demonstrated in the de-
veloping Xenopus embryos [7].
To unravel molecular mechanisms of MAK-V action and
regulation, and improve our understanding of the role of this
protein kinase in cell physiology, we searched for MAK-V-
interacting proteins in eukaryotic cells and found that the Nedd4
E3 ubiquitin ligase is able to interact with and affect activity of
MAK-V.
Results
Identification of Nedd4 as a MAK-V Binding Protein
To identify proteins that form complexes with MAK-V in vivo
we used PC12 cells with doxycycline inducible expression of C-
terminally FLAG-tagged MAK-V protein. Lysates of DOX-
induced and non-induced cells were loaded on anti-FLAG affinity
gel, and following thorough washes bound proteins were eluted
and resolved in SDS-PAGE to identify proteins co-purifying with
MAK-V. Comparison of eluted protein profiles from induced and
non-induced cells allowed us to distinguish between proteins
interacting with MAK-V from those absorbing non-specifically on
the affinity matrix. A prominent band of ,115 kD evident only in
samples purified from lysates of MAK-V-expressing cells (Fig. 1A)
was excised from the gel and subjected to trypsinization and
MALDI-TOF mass-spectrometry. Peptide fingerprint analysis
identified this protein as rat E3 ubiquitin ligase Nedd4. To
confirm the results of mass-spectrometry analysis and the
specificity of interaction, we immunoblotted anti-FLAG immuno-
precipitates with specific anti-Nedd4 antibodies. This demonstrat-
ed that Nedd4 protein indeed specifically co-precipitated with
MAK-V protein kinase (Fig. 1B). Reciprocal immunoprecipitation
with anti-Nedd4 antibodies also confirmed the existence of MAK-
V/Nedd4 complexes in cell lysates although some non-specific
MAK-V-FLAG protein absorption on the protein G matrix used
to immobilize anti-Nedd4 antibodies was observed (Fig. 1C). To
further prove that MAK-V specifically interacts with Nedd4,
lysates of MAK-V-FLAG expressing cells were incubated with
GST or GST-Nedd4 fusion protein immobilized on glutathione
Sepharose. As evident from Fig. 1D, GST-Nedd4 protein and not
GST is able to specifically pull down MAK-V-FLAG protein.
Together these data demonstrate that MAK-V protein kinase and
Nedd4 E3 ubiquitin ligase form specific complexes in cells.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39505Although these results unambiguously demonstrate specific
interaction between MAK-V and Nedd4, they were obtained in
experiments that analyzed interaction between endogenous or
recombinant Nedd4 and exogenously produced MAK-V. To
demonstrate interaction of endogenous MAK-V and Nedd4
proteins, we assayed the presence of MAK-V/Nedd4 complexes
in CSML-0 cells, which produce detectable amounts of endoge-
nous MAK-V protein [8], using co-immunoprecipitation ap-
proach. The CSML-0 cell lysate was incubated with Protein G
Sepharose beads (control immunoprecipitation) or Protein G
Sepharose beads conjugated with anti-Nedd4 antibodies and
immunoprecipitates were analyzed for the presence of MAK-V.
As evident from Fig. 2A, endogenous MAK-V protein is readily
detected in a fraction of proteins immunoprecipitated with anti-
Nedd4 antibodies but not in the control immunoprecipitate. To
further confirm the interaction between endogenous MAK-V and
Nedd4 proteins, we carried out reciprocal immunoprecipitation
experiments using anti-MAK-V antibodies. While Nedd4 protein
was readily detected in a fraction of proteins immunoprecipitated
with anti-MAK-V antibodies, virtually no Nedd4 protein was
present in control immunoprecipitates with anti-MAK-V anti-
bodies omitted (Fig. 2B). Together results of immunoprecipitation
experiments indicate that endogenous Nedd4 and MAK-V
proteins interact with each other.
Nedd4 belongs to a group of structurally related HECT-type E3
ubiquitin ligases with Nedd4-2 being the most closely related to
Nedd4 [9,10]. However, unlike Nedd4, we failed to detect specific
enrichment of the Nedd4-2 protein in anti-FLAG immunopreci-
pitates from lysates of MAK-V-FLAG expressing cells (data not
shown). This observation indicates that interaction with MAK-V is
specific for Nedd4 but not for Nedd4-2 E3 ubiquitin ligase despite
their high similarity.
Figure 1. Nedd4 specifically interacts with MAK-V. (A) Typical profile of proteins purified on anti-FLAG M2 affinity gel from PC12TetOn cells
treated with doxycycline (+) to express MAK-V-FLAG protein or left untreated (-). Silver-stained 4–12% gel is shown with positions of protein
molecular weight markers (MW) shown in kD on the left. Arrows marks MAK-V-FLAG protein (*) and Nedd4 protein co-purified with MAK-V-FLAG (**).
(B) Samples from (A)( IP anti-FLAG) and aliquots of cell lysates prior to purification (Input) were stained with anti-Nedd4 (anti-Nedd4) or anti-FLAG
(anti-FLAG) antibodies. (C) Lysate of PC12TetOn cells treated with doxycycline to express MAK-V-FLAG protein was incubated with Protein G
Sepharose (no Ab) or Protein G Sepharose with immobilized anti-Nedd4 antibodies (Nedd4 Ab). Bound proteins were analyzed by Western blotting
with anti-FLAG (anti-FLAG) or anti-Nedd4 (anti-Nedd4) antibodies. (D) Proteins were pulled down from lysate of PC12TetOn cells treated with
doxycycline to express MAK-V-FLAG protein with GST (GST) or GST-Nedd4 (GST-Nedd4) proteins immobilized on glutathione Sepharose. MAK-V-FLAG
protein was detected with anti-FLAG antibodies (anti-FLAG). To monitor GST protein loading of glutathione Sepharose, eluted proteins were stained
with anti-GST antibodies (anti-GST). Arrowhead marks full-length GST-Nedd4 chimeric protein.
doi:10.1371/journal.pone.0039505.g001
Figure 2. Interaction between endogenous Nedd4 and MAK-V
proteins. Proteins were immunoprecipitated from lysates of CSML-
0 cells with anti-Nedd4 (A; IP: Nedd4 Ab) or anti-MAK-V antibodies (B; IP:
MAK-V Ab). Control immunoprecipitations with omitted antibodies were
run in parallel (IP: control). Immunoprecipitates and aliquots of lysates
used for immunoprecipitation (Input) were probed with anti-MAK-V
(anti-MAK-V) and anti-Nedd4 (anti-Nedd4) antibodies to detect MAK-V
and Nedd4 proteins, respectively.
doi:10.1371/journal.pone.0039505.g002
MAK-V Interacts with Nedd4
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39505Mapping Interaction between MAK-V and Nedd4
Domain organization of rodent Nedd4 is typical for Nedd4-like
HECT-type E3 ubiquitin ligases with a C2 domain on the N-
terminus followed by three WW domains and a C-terminally
located catalytic HECT domain [11] (Fig. 3A). The interaction of
HECT ligases with other proteins is usually mediated by WW
domains via proline-rich PY-motifs on their interacting partners
[9,10,12]. However MAK-V lacks any consensus PY-motif, which
suggests a non-canonical mechanism of molecular interaction with
Nedd4. Indeed, analysis of interaction between MAK-V and
various Nedd4 deletion mutants in the yeast two-hybrid system
showed that C2 and the first WW1 domain are sufficient to
mediate MAK-V binding while WW domains alone failed to
interact with MAK-V (Fig. 3A). Reciprocal experiments with
deletion mutants of MAK-V demonstrated that the N-terminal
region of the MAK-V polypeptide chain containing protein kinase
catalytic and SNH/UBA domains but not a unique C-terminal
region, provides interaction interface with Nedd4 (Fig. 3B). This
part of MAK-V is also involved in the interaction with all but one
[13] known binding partners of this protein.
MAK-V is Subjected to Proteasome-dependent
Degradation
The identified physical interaction between MAK-V and Nedd4
suggests that this E3 ubiquitin ligase might target MAK-V for
ubiquitin-dependent degradation. Noteworthy, MAK-V has been
previously suggested to be ubiquitinated [14]. Therefore we
assessed whether MAK-V undergoes proteasome-dependent
degradation in cells. Treatment of MAK-V-FLAG expressing
PC12 cells with the proteasome inhibitor ALLN resulted in an
increase in MAK-V-FLAG protein content concomitant with
appearance of anti-FLAG reactive protein species of higher
molecular weights, which is typical for ubiquitinated proteins
targeted to degradation upon proteasome inhibitor treatment
(Fig. 4A). This result indicates that MAK-V is indeed targeted to
proteasome-dependent degradation. Similar alterations in the
pattern of anti-FLAG immunoreactivity were observed following
the treatment of HEK293 cells transiently expressing MAK-V-
FLAG protein with MG132 proteasome inhibitor (Fig. 4B).
Increase in MAK-V protein content in both PC12TetOn and
HEK293 cells upon proteasome function inhibition suggests that
the control of MAK-V abundance in cells by proteasome-
dependent degradation is not a cell type-specific mechanism.
Although MAK-V was previously revealed as an ubiquitinated
protein in proteome-wide analysis [14], there is no direct evidence
of MAK-V ubiquitination. To directly demonstrate that MAK-V
is modified by ubiquitin, HEK293 cells were co-transfected with
a HA-tagged ubiquitin expression plasmid alone or together with
a plasmid encoding MAK-V-FLAG protein. After treatment with
MG132, proteins were precipitated from cell lysates with anti-
FLAG antibodies and the presence of ubiquitinated proteins in
immunoprecipitates was analyzed by immunoblotting with anti-
HA antibodies. As evident from Fig. 4C, ubiquitinated proteins
are detected only if MAK-V-FLAG protein was present in cell
lysate used for anti-FLAG immunoprecipitation. This suggests that
the ubiquitinated protein is MAK-V protein kinase. Moreover, co-
transfection of HEK293 cells with MAK-V-FLAG expression
plasmid and a plasmid encoding wild-type ubiquitin or its K48R
or K63R mutant resulted in a marked increase of MAK-V-FLAG
protein only when co-expressed with ubiquitin bearing K48R
mutation, which is deficient in polyubiquitin chain formation
(Fig. 4D). As K48R ubiquitin mutant expression has a dominant
effect on the degradation of ubiquitinated proteins (see, for
example, [15,16]), these results indicate that the MAK-V protein is
degraded in an ubiquitin-dependent manner. Together, our data
provide evidence of ubiquitin-dependent degradation of MAK-V
protein kinase in cells.
Nedd4 is not Involved in MAK-V Degradation
Next we questioned if Nedd4 was an E3 ubiquitin ligase for
MAK-V. When MAK-V-FLAG protein purified from PC12 cells
was used in in vitro ubiquitination assay with different E2 ubiquitin-
conjugating enzymes, a pronounced ubiquitin smear starting from
the MAK-V protein band position was evident for Ubc5a, 5b and
5c E2 proteins but not for other E2 proteins assayed (Fig. 5A). The
observed E2 enzyme specificity of polyubiquitin chain formation
well fit to the E2 protein preference for Nedd4 [17], which is
present in MAK-V-FLAG protein preparation used (see Fig. 1).
However we failed to detect anti-MAK-V or anti-FLAG reactive
species with a molecular weight higher than that of unmodified
MAK-V-FLAG protein in in vitro ubiquitination reaction products
(data not shown), which contradicts the idea that the observed
ubiquitin smears represent ubiquitinated MAK-V-FLAG protein.
We also attempted to reconstitute in vitro MAK-V protein
ubiquitination by Nedd4 using recombinant Nedd4 and MAK-V
proteins either produced by in vitro translation, or expressed in
E.coli, or purified from transfected mammalian cells. However we
repeatedly failed to observe MAK-V modification by ubiquitin
(data not shown), which further suggests that MAK-V is not
a Nedd4 substrate for ubiquitination. To ultimately prove this, we
assayed whether Nedd4 is dispensable for MAK-V destabilization
in PC12 cells. We generated clones of MAK-V-FLAG producing
cells with expression of microRNA to deplete Nedd4 protein or
with control microRNA, and assayed if depletion of Nedd4 would
result in the loss of proteasome inhibitor-dependent stabilization of
MAK-V-FLAG protein. Expression of Nedd4 microRNA resulted
in significant reduction of Nedd4 protein levels while control
microRNA had no effect (Fig. 5B). Treatment with both MG132
and ALLN proteasome inhibitors led to similar stabilization of
MAK-V-FLAG protein independently of Nedd4 presence in cells
(Fig. 5B), suggesting that depletion of Nedd4 does not affect MAK-
V stability. Consistently with the suggestion that Nedd4 is not able
to ubiquitinate MAK-V, a higher molecular weight anti-FLAG
reactive band attributed to MAK-V ubiquitination was observed
in in vitro ubiquitination reaction products with MAK-V-FLAG
and cytosolic proteins derived from Nedd4 depleted cells (Fig. 5C).
Taken together, our data strongly suggest that MAK-V is not
a target for ubiquitination by Nedd4.
Although MAK-V failed to interact with Nedd4-2, an ubiqutin
ligase most closely structurally related to Nedd4, it cannot be
excluded that E3 ubiquitin ligase redundancy in cells may obscure
the effect of Nedd4 depletion on MAK-V protein stability. To
resolve this issue, the effect of Nedd4 overexpression on MAK-V
stability was assessed. As PC12TetOn cells express high levels of
endogenous Nedd4 protein, we used HEK293 cells expressing
a significantly lower level of this protein (data not shown).
Overexpression of Nedd4 should result in the down-regulation of
MAK-V protein steady-state level and decreased the protein half-
life, provided that Nedd4 is a E3 ubiquitin ligase for MAK-V. As
a reference control, we used a catalytically inactive Nedd4(CS)
mutant which might also act in a dominant-negative mode
through target protein sequestration and thus preventing them
from being ubiquitinated and subsequently degraded. However,
we failed to reveal any difference in the steady-state levels of
MAK-V-FLAG protein transiently expressed in HEK293 cells
together with wild-type or mutant Nedd4 (Fig. 6A). Accordingly,
no differences were observed in kinetics of MAK-V protein decay
after de novo protein synthesis was blocked by cycloheximide
MAK-V Interacts with Nedd4
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a MAK-V E3 ubiquitin ligase and does not regulate MAK-V
protein stability in cells.
Nedd4 Affects MAK-V Functions Independently of E3
Ubiquitin Ligase Activity
It has been shown previously that overexpression of MAK-V in
Xenopus embryos inhibits convergent extension movements
through the regulation of Wnt signaling [7]. We used this system
to investigate if Nedd4 can affect MAK-V function. Consistent
with the previous report [7], injection of 1–2 ng of MAK-V mRNA
into two dorso-animal blastomeres at the 4–8 cell stage resulted in
strong morphogenetic abnormalities at stage 38 (Fig. 7). Injection
of 2 ng of Nedd4 mRNA or mRNA for expression of catalytically
inactive Nedd4(CS) mutant did not cause any gross abnormalities.
However co-injection of Nedd4 and MAK-V mRNAs rescued the
effect of MAK-V on convergent extension movements. Consis-
tently with the lack of Nedd4-dependent ubiquitination of MAK-
V, a similar effect was observed upon Nedd4(CS) expression
(Fig. 7). Thus Nedd4 in an ubiquitin ligase-independent manner is
capable of suppressing MAK-V-induced developmental defects in
the Xenopus embryo, thus demonstrating functional interplay
between the two proteins and supporting the physiological
relevance of the revealed interaction between Nedd4 and MAK-V.
Discussion
Since its identification and cloning, MAK-V protein kinase has
been expected to play a role in tumorigenesis [2,18]. This has been
supported by frequently observed MAK-V overexpression in
human breast tumors [19]. Pro-survival and anti-apoptotic
Figure 3. Mapping of interaction between Nedd4 and MAK-V proteins in yeast two-hybrid system. (A) Domain structure of mouse
Nedd4 protein showing positions (in aa) of C2, WW and HECT domains. The scheme below illustrates organization of GAL4AD proteins fused to
various fragments of Nedd4, which were used in the yeast two-hybrid assay. On the right, results of analysis of interaction between GAL4BD fused to
MAK-V protein (pPC97-MAK-V) and GAL4AD fused to various fragments of Nedd4 are shown. Protein interaction was monitored by ability of yeast to
grow in the presence of 3AT (+3AT). To monitor specificity, interaction with GAL4BD alone (pPC97) was monitored in the same assay. (B) Domain
structure of mouse MAK-V protein kinase showing positions (in aa) of catalytic (S_TKc) and SNH/UBA domains and C-terminal region (C-term). The
scheme below illustrates organization of GAL4BD proteins fused to full-length of MAK-V or its N- or C-terminal fragments, which were used in the
yeast two-hybrid assay. On the right, results of analysis of interaction between GAL4AD fused to fragment encompassing C2 and tree WW domains of
Nedd4 (pPC86-C2-WW1-3) and GAL4AD fused to MAK-V fragments are shown. Protein interaction and specificity were monitored as described above.
doi:10.1371/journal.pone.0039505.g003
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implicated MAK-V in tumor cell biology [3–5]. The revealed role
of MAK-V in cancer provides a rational basis to consider MAK-V
as a target in anti-cancer therapy. However in different types of
tumor cells MAK-V expression either promoted [4] or suppressed
[5] their metastasis potential. Moreover, in different experimental
models MAK-V appeared to be either essential [3] or dispensable
[4] for tumorigenesis itself. This apparent contradiction is likely to
be caused by specific functional consequences of MAK-V
expression within different cellular contexts. In turn, this
emphasizes the importance of better understanding of MAK-V
molecular mechanisms of action and regulation. This knowledge is
required for discriminating between tumors in which MAK-V
expression is pro-carcinogenic and those in which MAK-V
expression is dispensable for or even suppresses metastasis. Here
we revealed two possible modes of MAK-V regulation – control of
MAK-V protein abundance through proteasomal degradation and
Nedd4-dependent functional suppression of MAK-V.
Identification of interaction partners is a powerful approach for
integrating a protein of interest into particular chain of molecular
events. Here we identified HECT-type E3 ubiquitin ligase Nedd4
as a most prominent binding partner of MAK-V in PC12 cells and
confirmed that two proteins can form a complex when expressed
in cells. WW domains of HECT type ubiquitin ligases usually
Figure 4. MAK-V is subjected to ubiquitin-dependent proteasomal degradation. (A) Doxycycline-treated (DOX +) or untreated (DOX -)
PC12TetOn MAK-V-FLAG cells were incubated with 100 mM of ALLN (ALLN +) or vehicle (ALLN -) for 8 hrs. Results of Western blot analysis of total cell
lysates with anti-FLAG antibodies are shown. MAK-V-FLAG protein marked with arrow, ubiquitinated higher molecular weight MAK-V-FLAG species
marked by asterisk. To monitor total protein loading, membrane was re- probed with anti-a-tubulin antibodies. (B) HEK293 cells were transiently
transfected with plasmid for MAK-V-FLAG protein expression and treated with 10 mM MG132 (MG+) for indicated time prior to lysis or left untreated
(MG-). Lysates were blotted with anti-FLAG antibodies to detect MAK-V-FLAG protein (anti-FLAG). To monitor total protein loading, membrane was re-
probed with anti-a-tubulin antibodies. (C) HEK293 cells were transfected with plasmid for HA-tagged ubiquitin expression alone (MAK-V-FLAG -)o r
together with plasmid for MAK-V-FLAG protein expression (MAK-V-FLAG +). Cells were treated with MG132 prior to lysis. MAK-V-FLAG protein was
precipitated from lysates with anti-FLAG M2 affinity gel as described for PC12TetOn cells. Anti-FLAG antibodies were used to detect MAK-V-FLAG
protein (anti-FLAG) in immunoprecipitates (IP: anti-FLAG), and ubiquitin was detected with anti-HA antibodies (anti-HA). To monitor HA-tagged
ubiquitin and MAK-V-FLAG protein expression, aliquots of lysates were blotted as described above. To monitor total protein loading, membrane was
re-probed with anti-a-tubulin antibodies. (D) HEK293 cells were co-transfected with MAK-V-FLAG expression plasmid and plasmid for expression of
FLAG-tagged wild-type ubiquitin (wt), its K48R (K48R) or K63R (K63R) mutant. Results of Western blot analysis of total cell lysates with anti-MAK-V
antibodies are shown. To monitor total protein loading, membrane was re-probed with anti-a-tubulin antibodies. To control variations in basal level
of MAK-V-FLAG protein expression, samples were also probed with antibodies against neomycin phosphotransferase II (anti-NPT) which is encoded
by MAK-V-FLAG expression vector.
doi:10.1371/journal.pone.0039505.g004
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specificity of ubiquitin-ligase activity co-purified with MAK-V-FLAG
protein. MAK-V-FLAG protein purified from PC12TetOn cells was used in
in vitro ubiquitination reactions containing E1 enzyme and indicated E2
ubiquitin-conjugating enzymes. Results of Western blotting with HRP-
conjugated streptavidin to detect ubiquitinated proteins/polyubiquitin
(marked by asterisk) are shown. The image was overlaid with an image
of the same membrane that was consequently probed with anti-FLAG
antibodies to detect MAK-V-FLAG protein (marked by arrows). (B)
Depletion of Nedd4 does not affect stabilization of MAK-V-FLAG protein
in cells in response to treatment with proteasome inhibitors. Parental
PC12TetOn cells with inducible MAK-V FLAG expression (no miR)o r
their clonal derivatives expressing control microRNA (control miR) or
microRNA to target Nedd4 transcript (Nedd4 miR) were treated with
doxycycline to express MAK-V-FLAG protein and incubated with
100 mM of ALLN (ALLN)o r1 0mM of MG132 (MG132) for 8 hrs or left
untreated (-). Results of Western blot analysis of total cell lysates with
anti-FLAG antibodies are shown (anti-FLAG). Nedd4 level was monitored
with anti-Nedd4 antibodies (anti-Nedd4). MAK-V-FLAG protein marked
with arrow, ubiquitinated higher molecular weight MAK-V-FLAG species
marked by asterisk. Membrane was also probed with anti-a-tubulin
antibodies (anti-a-tubulin) to monitor total protein loading. (C) MAK-V-
FLAG protein and cytosols were prepared from parental PC12TetOn
cells with inducible MAK-V-FLAG expression (Nedd4+) or its Nedd4-
depleted clonal derivative expressing Nedd4 microRNA (Nedd4 -) and
used in in vitro ubiquitination reaction containing E1 and UbcH5b E2
enzymes. Results of Western blot analysis with anti-FLAG antibodies are
shown. Arrow marks products of MAK-V ubiquitination. Reactions in the
presence of EDTA (EDTA +) were used as negative controls.
doi:10.1371/journal.pone.0039505.g005
Figure 6. Nedd4 does not affect MAK-V protein level. (A)
HEK293 cells were transfected with MAK-V-FLAG expression plasmid
(MAK-V-FLAG +) together with plasmid for expression of myc-tagged
wild-type Nedd4 (wt) or its catalytically inactive Nedd4(CS) mutant (CS),
or mock-untransfected (-). Cells were treated by MG132 prior to lysis
(MG132+) or left untreated (MG132 -). Results of Western blot analysis of
total cell lysates with anti-FLAG antibodies are shown (anti-FLAG).
Nedd4 levels were monitored with anti-Nedd4 antibodies (anti-Nedd4),
and exogenously expressed myc-tagged Nedd4 proteins were detected
with anti-myc antibodies (anti-myc). To monitor total protein loading,
membrane was re-probed with anti-a-tubulin antibodies. (B) HEK293
cells were co-transfected with MAK-V-FLAG expression plasmid and
plasmid for expression of myc-tagged wild-type Nedd4 (Nedd4 wt) or its
catalytically inactive Nedd4(CS) mutant (Nedd4(CS)). Cells were treated
with cycloheximide for indicated time prior to lysis. Representative
results of Western blot analysis of total cell lysates with anti-FLAG
antibodies to detect MAK-V-FLAG protein are shown (anti-FLAG). To
monitor total protein loading, membrane was re-probed with anti-a-
tubulin antibodies. (C) Quantification of MAK-V-FLAG protein level in
HEK293 cells when co-expressed with wild-type Nedd4 (Nedd4 wt)o r
with its Nedd4(CS) (Nedd4 CS) mutant after cycloheximide treatment.
Relative MAK-V-FLAG protein levels for each time point of cyclohexi-
mide treatment indicated in hours (hrs) were determined by
quantification of Western blot images obtained as described in (B).
Data are presented as means 6 standard deviation of three
independent experiments performed as described in (B).
doi:10.1371/journal.pone.0039505.g006
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a partner protein and also can interact with phosphoserine/
phosphothreonine residues, although with lower affinity
[9,10,12,20]. In addition, interaction of many proteins with
Nedd4 family ubiquitin ligases is known to be mediated by adaptor
proteins containing PY-motif capable to bind WW domains of
these ubiquitin ligases [10]. The MAK-V protein lacks any
consensus PY-motif but WW1 domain of Nedd4 is still required
for MAK-V binding. Yet our experimental data did not confirm
that WW domains (WW1-WW3) of Nedd4 alone are capable of
conferring interaction with MAK-V, which might be explained by
low affinity of this interaction. As MAK-V protein is known to be
abundantly phosphorylated in cells [21], it becomes feasible that
Nedd4 WW domains might secure low affinity binding to
phosphorylated serine and/or threonine residue(s) in MAK-V
with the additional interaction with the C2 domain of Nedd4
required to stabilize MAK-V/Nedd4 complexes.
Although our data suggested that Nedd4 is not an ubiquitin
ligase for MAK-V, Nedd4 was capable of rescuing developmental
defects in Xenopus embryos caused by MAK-V overexpression.
This demonstrates that Nedd4 is a regulator of MAK-V functional
activity, ultimately confirming physiological relevance of the
identified interaction between MAK-V and Nedd4. The ability
of both wild type and ubiquitin ligase-deficient Nedd4 to rescue
the MAK-V overexpression phenotype in Xenopus embryos
indicates that ubiquitin ligase activity is dispensable for Nedd4-
mediated regulation of MAK-V.
The simplest model of MAK-V regulation by Nedd4 assumes
sequestration of MAK-V protein kinase catalytic activity through
interaction with Nedd4. Indeed, Nedd4 binds to the N-terminal
part of MAK-V encompassing catalytic and SNH/UBA domains,
both of which are required for catalytic activity of related protein
kinases [22,23]. However other scenarios of Nedd4-dependent
suppression of MAK-V can be proposed, and the molecular
mechanism of MAK-V suppression by Nedd4 is yet to be
investigated.
The revealed interaction between MAK-V protein kinase and
Nedd4 provide a mechanistic basis for potential regulation of
Nedd4 activity by MAK-V phosphorylation. Indeed, functions of
Nedd4-like E3 ubiquitin ligases are regulated by phosphorylation,
which might either positively or negatively regulate their activities
[10]. Thus, it is important to further investigate the role of MAK-
V protein kinase in regulation of Nedd4 activity and Nedd4-
controlled cellular processes.
Taken together, we found that MAK-V protein kinase is
capable of interacting with Nedd4 ubiquitin ligase. Detection of
endogenous Nedd4/MAK-V complexes proves that this interac-
tion takes place in physiological conditions. Although molecular
mechanisms of mutual effects of these two proteins on each other
functions remain to be elucidated, we showed that Nedd4
counteracts effect of MAK-V overexpression on Xenopus embryo
development. This observation suggests physiological relevance of
the identified interaction between MAK-V and Nedd4.
Figure 7. Nedd4 regulates MAK-V activity. Nedd4 in ubiquitin ligase-independent manner rescue axis extension defects in Xenopus
development induced by MAK-V overexpression. Two ng each of MAK-V, Nedd4, Nedd4(CS) mRNA was injected alone or together as indicated into
two dorso-animal blastomeres at 4–8 cell stage. Embryos were fixed at stage 38.
doi:10.1371/journal.pone.0039505.g007
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Plasmids
Nedd4 cDNA fragment encoding full-length Nedd4 except for
the first 33 amino acids (aa 34-887) was excised with BamHI and
NotI restriction endonucleases from EST clone IMAGE:6330296
(American Tissue Culture Collection; GeneBank Accession No.
BQ885745). The excised fragment was subcloned in-frame into
the pBK-CMV plasmid (Stratagene, USA) engineered to contain
the fragment of preproinsulin cDNA 59-untranslated region, ATG
codon and sequence encoding myc epitope downstream CMV
promoter [24]. Nedd4 cDNA linked to preproinsulin cDNA 59-
untranslated region, the ATG codon and sequence encoding myc
epitope was then cloned into pSP64(PolyA) vector (Promega, USA)
to generate pSP64-Nedd4 plasmid for Nedd4 mRNA in vitro
transcription. PCR-directed mutagenesis was used to introduce
C854S mutation into Nedd4 cDNA resulting in catalytically
inactive Nedd4(CS) ubiquitine ligase [25]. The presence of
introduced substitutions was confirmed by sequencing. pSP64-
Nedd4(CS) plasmid for Nedd4(CS) mRNA in vitro transcription was
constructed as described above for pSP64-Nedd4 plasmid.
The pGEX-Nedd4 plasmid for expression of Nedd4 protein (aa
34-887) fused to glutathione-S-transferase (GST) was constructed
by cloning the respective Nedd4 cDNA fragment into pGEX-4T-2
plasmid (GE Healthcare, USA).
Predesigned BLOCK-iT miR RNAi Select hairpin (Invitrogen,
USA) to target the rat Nedd4 transcript was obtained by annealing
oligonucleotides 59-tgc tga taa atc tca ggt cca gct ccg ttt tgg cca ctg
act gac gga gct ggc tga gat tta t-39 (top strand) and 59-cct gat aaa
tct cag cca gct ccg tca gtc agt ggc caa aac gga gct gga cct gag att tat
c-39 (bottom strand) and cloning into pcDNA6.2-GW/EmGFP-
miR vector using BLOCK-iT PolII miR RNAi Expression Vector
kit (Invitrogen, USA). The resulting pcDNA6.2-GW/EmGFP-
miR-rNedd4 plasmid codes for Nedd4 microRNA together with
EmGFP fluorescent protein. As a control, pcDNA6.2-GW/
EmGFP-miR-neg control plasmid (Invitrogen, USA) for expres-
sion of hairpin predicted not to target any known vertebrate gene
was used.
Plasmids pPC97 and pPC86 for analysis of protein-protein
interaction in yeast were described previously [26], as well as
plasmids for expression of DNA-binding domain of GAL4
transcription factor (GAL4BD) fused to mouse MAK-V protein
(aa 26-714; pPC97-MAK-V), its N-terminal part (aa 26-394;
pPC97-N-MAK-V) or complementary C-terminal portion (aa
395-714; pPC97-C-MAK-V) [27]. To construct plasmids for
expression of Nedd4 fragments fused to GAL4 activator domain
(GAL4AD) in yeast, respective Nedd4 cDNA fragments excised
with appropriate restriction endonucleases or amplified in PCR
were cloned into multiple cloning site of the pPC86 vector. The
following plasmids were constructed: pPC86-C2 (Nedd4 aa 34-271
containing C2 domain; see Fig. 3A for domain positions in Nedd4
protein), pPC86-C2-WW1 (Nedd4 aa 34-295 containing C2 and
WW1 domains), pPC86-C2-WW1-2 (Nedd4 aa 34-440 containing
C2, WW1 and WW2 domains), pPC86-C2-WW1-3 (Nedd4 aa 34-
493 containing C2 and all three WW domains), pPC86-WW1-3
(Nedd4 aa 220-493 containing only three WW domains), and
pPC86-WW1-3-H (Nedd4 aa 220-887 containing WW1-3 and
HECT domains). Details of cloning are available on request.
Plasmids for expression of Ha-tagged ubiquitin [28] and C-
terminally FLAG-tagged MAK-V protein kinase [21] were
described before. Plasmids for expression of FLAG-tagged
ubiquitin and its K48R and K63R mutants were a gift from Dr.
Ajay Chitnis (National Institutes of Health, Bethesda, MD, USA).
Cells
PC12TetOn cells (Clontech, USA) with inducible expression of
mouse MAK-V-FLAG protein were cultured as described before
[6]. For total cell lysate preparation, cells were plated in 24-well
plates (300000 cells per well). If required, cells were treated with
1 mg/ml doxycyline for 2 days prior to lysis. If indicated, cells were
treated with 10 mM MG132 (Calbiochem, USA) or 100 mM
ALLN (Sigma, USA) prior to lysis.
To generate microRNA-expressing clones, cells were trans-
fected with pcDNA6.2-GW/EmGFP-miR-neg control (Invitro-
gen, USA) or pcDNA6.2-GW/EmGFP-miR-rNedd4 plasmid and
clones were selected in the presence of 2 mg/ml of blasticidin.
Homogeneity of the cell population in isolated clones was
monitored by EmGFP fluorescence.
CSML-0 cell line established from a mammary adenocarcino-
ma was described before [29]. Cells were cultured in DME
medium supplemented with 10% fetal bovine serum, 100 units/ml
of penicillin and 100 mg/ml of streptomycin.
HEK293 cells (European Collection of Cell Cultures,
85120602) were cultured on DME medium supplemented with
10% fetal bovine serum, 100 units/ml of penicillin and 100 mg/ml
of streptomycin. Cells were transfected using Unifectin-56 trans-
fection reagent (Unifect Group, Russia). Cells were lysed 2 days
after transfection. If indicated, cells were treated with 10 mM
MG132 (Calbiochem, USA) for 24 hrs (or 8 and 16 hrs if
specified) prior to lysis.
Isolation of MAK-V-FLAG Protein and MAK-V-interacting
Proteins
To isolate MAK-V-FLAG protein and MAK-V-interacting
proteins, four 100 mm plates of PC12TetOn cells with inducible
MAK-V-FLAG expression were treated with 1 mg/ml of doxicyx-
line for 2 days to induce MAK-V-FLAG expression or left
untreated. Subconfluent cells were washed in ice-cold PBS,
collected in microcentrifuge tubes and lysed in 0.5 ml/plate of
lysis buffer (1x tris-buffered saline, pH 8.0 (TBS); 1% Nonident P-
40; 0.5% Triton X100; 1 mM MgCl2; 0.2 mM EGTA; 1x
Complete EDTA-free Protease Inhibitor Cocktail (Boehringer
Mannheim, Germany), 1x Phosphatase Inhibitor Cocktails I and
II (Sigma, USA)) at 4uC for 15 min. Lysates were cleared by
centrifugation (4500 g, 10 min, 4uC) and incubated with 50 mlo f
EZview Red anti-FLAG M2 affinity gel (Sigma, USA) at 4uC for
2 hrs. The gel was washed 3 times with 500 ml of ice-cold lysis
buffer and bound proteins were eluted by sequential incubation for
30 min with 50 ml and 25 ml of TBS containing 100 mg/ml of
FLAG peptide (Sigma, USA). Eluted proteins were resolved in
NuPAGE Bis-Tris 4–12% gel and stained with either SilverXpress
Silver Staining Kit (Invitrogen, USA) or Coomassie stain. Protein
bands were cut from Coomassie stained gels and trypsinized for
further analysis by peptide fingerprint analysis. Mass-spectrometric
analysis of protein tryptic digest was done on Ultraflex MALDI-
TOF mass spectrometer (Bruker-Daltonics, Germany). Proteins
were identified using Mascot program (Matrix Science, USA).
Cytosol Fraction and Total Cell Lysate Preparation
Cytosol was prepared from PC12TetOn clones as described
before [8]. To prepare total cell lysates, cells in wells of 24-well
plate were washed with ice-cold PBS and lysed in 120 ml of SDS-
PAGE loading buffer. Lysates were boiled prior to loading on the
gel. CSML-0 cell lysates for immunoprecipitation were prepared
essentially as described for lysate preparation for isolation of
MAK-V-FLAG protein but 250 ml of lysis buffer were used to lyse
cells from subconfluent 100 mm cell culture dish.
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Proteins were resolved in SDS-PAGE and transferred to
Hybond P membrane (GE Healthcare, Little Chalfont, UK).
Membranes were incubated with primary rabbit polyclonal anti-
FLAG (Sigma, USA), anti-Nedd4 (Abcam, UK), anti-Nedd4-2
[30], or anti-neomycin phosphotransferase II (Millipore, USA),
mouse monoclonal anti-a-tubulin, clone DM1A antibodies (Sig-
ma, USA) or affinity purified rat anti-MAK-V antibodies [8]
followed by secondary anti-rabbit, anti-mouse or anti-rat horse-
radish peroxidase-conjugated antibodies (HRP; GE Healthcare,
USA) as described previously [31]. To detect GST, anti-GST
HPR conjugate (GE Healthcare, USA) was used. Biotinylated
proteins were detected with HRP-conjugated streptavidin (Cal-
biochem, USA). Immobilon Western Chemiluminescent HRP
Substrate (Millipore, Billerica, MA, USA) or ECL+ reagent (GE
Healthcare, USA) were used for detection. Images were acquired
on ChemiDoc XRS gel documentation system (BioRad, Hercules,
CA, USA).
Quantification of MAK-V-FLAG Protein Level in
Cycloheximide-treated Cells
HEK293 were treated with 10 mM cycloheximide (Fluka,
Switzerland) for 0, 1, 2, 3 or 4 hrs prior to lysis in SDS-PAGE
loading buffer. Lysates were first immunoblotted with anti-FLAG
antibodies, and after washing the blot was re-probed with anti-a-
tubulin antibodies. Chemiluminescence was detected with Che-
miDoc XRS gel documentation system (BioRad) and quantified
with QuantityOne 4.6.2 software (BioRad). The levels of MAK-V-
FLAG protein for each time point were first normalized to a-
tubulin level, and then expressed as percentage of the MAK-V-
FLAG protein level at 0 hr point taken as 1.00. Each experiment
was repeated three times, and percentage of MAK-V-FLAG
protein levels for each time point was calculated as average in
three experiments 6 standard deviation.
In vitro Ubiquitination Assay
In vitro ubiquitination with biotinylated ubiquitin was performed
in 20 ml reactions using Ubiquitinylation kit (Biomol, USA)
according to supplier’s instructions. Seventy (if cytosol was added
to reaction) or 130 ng (if cytosol was omitted) of purified MAK-V-
FLAG protein and 9.6 mg of cytosolic proteins, if included, were
used in each reaction. Reaction products were analyzed by
Western blotting with either protein specific antibodies or total
ubiquitin was detected with HRP-conjugated streptavidin.
GST Pull-down Assay
GST and GST-Nedd4 proteins were expressed in Rozetta-
gammi E.coli (Novagen, USA) transformed with pGEX-4T-2 and
pGEX-Nedd4 plasmids, respectively, and purified on glutathione
Sepharose (GE Healthcare, USA) according to manufacturer’s
recommendations. Eluted proteins were dialyzed against PBS and
stored at 270uC. Glutathione Sepharose beads (20 ml) were
incubated with 30 mg of GST or GST-Nedd4 protein for 1 hr at
4uC with rotation and washed to remove unbound protein. Beads
were blocked with 0.2 mm-filtered 3% membrane blocking agent
(GE Healthcare, USA) in TBS for 30 min at 4uC, washed in TBS
and incubated for 2 hrs at 4uC with 50 ml of MAK-V-FLAG
expressing cell lysate prepared as described above for MAK-V-
FLAG protein purification. Beads were washed with lysis buffer
and bound proteins were eluted by boiling in SDS-PAGE sample
buffer. Eluted proteins were analyzed by Western blotting with
anti-FLAG antibodies to detect MAK-V-FLAG protein, and with
anti-GST antibodies to monitor GST protein loading.
Immunoprecipitation
Five hundred ml of CSML-0 cell lysate were incubated
overnight in SigmaPrep Spin column (Sigma, USA) at 4uC with
2 mg of anti-Nedd4 antibodies (Abcam, UK), 4 mg of anti-MAK-V
antibodies [8], or without antibodies added (control immunopre-
cipitations). After that, 20 ml of Protein G Sepharose beads (GE
Healthcare, USA) were added, and incubation was continued with
rotation for 4 hrs at 4uC. Beads were washed 3 times with ice-cold
buffer used to prepare cell lysates, and transferred as a suspension
to Eppendorf tube. After brief centrifugation, supernatant was
aspirated with 30G needle, and 20 ml of SDS-PAGE loading
buffer were added to beads to elute proteins. Samples were boiled
prior to loading on the gel. For control, immunoprecipitation
samples were processed in a similar way but antibodies were
omitted in primary incubation with Protein G Sepharose.
Protein Interactions in Yeast Two-hybrid System
Analysis of protein interactions in yeast was done essentially as
described before [1] using yeast expressing assayed proteins as
chimeras with GAL4BD and GAL4AD. Interaction was moni-
tored by activation of the HIS3 reporter gene by the ability of yeast
to grow on minimal medium supplemented with 60 mM 3-amino-
(1,2,4)-triazole (3AT; Sigma, USA).
Experiments with Xenopus Embryos
Synthesis of mouse MAK-V RNA for injection, embryo culture
and microinjection were done essentially as described before [7].
Mouse Nedd4 and Nedd4CS RNAs for microinjection were
synthesized from pSP64-Nedd4 and pSP64-Nedd4(CS) plasmids,
respectively, using mMessage mMashine kit (Ambion, USA). One-
to-two nanogram of MAK-V, Nedd4,o rNedd4(CS) mRNA were
injected alone or together into two dorso-animal blastomeres at 4–
8 cell stage, and morphological phenotypes were evaluated at
stages 35–38.
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